tyrosine has been researched along with Neuroendocrine Tumors in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Grineva, E; Mitrofanova, L; Ryzhkova, D; Schlyakhto, E; Tsoy, U | 1 |
Cantone, MC; Dicitore, A | 1 |
Reubi, JC; Waser, B | 1 |
Abe, M; Akiba, J; Ikezono, Y; Iwamoto, H; Koga, H; Masuda, A; Nakamura, T; Sakaue, T; Torimura, T; Tsuruta, O; Wada, F; Yano, H; Yoshida, T | 1 |
Delle Fave, G; Di Florio, A; Jensen, RT; Moreno, P; Sancho, V | 1 |
Aghi, MK; Brumwell, AN; Chapman, HA; Jablons, DM; Kwan, I; McDonald, DM; Sennino, B; Tan, K; Ulsamer, A; Wei, Y; Xi, Y | 1 |
DeJesus, OT; Flores, LG; Murali, D; Nickles, RJ; Roberts, AD | 1 |
Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S | 1 |
1 review(s) available for tyrosine and Neuroendocrine Tumors
Article | Year |
---|---|
Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.
Topics: Adrenocorticotropic Hormone; Biological Products; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin; Tyrosine | 2022 |
7 other study(ies) available for tyrosine and Neuroendocrine Tumors
Article | Year |
---|---|
Targeting receptor tyrosine kinases in neuroendocrine neoplasm: what's going on with lung carcinoids?
Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Tyrosine | 2022 |
Triple-peptide receptor targeting in vitro allows detection of all tested gut and bronchial NETs.
Topics: Autoradiography; Bronchial Neoplasms; Glucagon-Like Peptide-1 Receptor; Humans; Insulinoma; Iodine Radioisotopes; Ligands; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Protein Binding; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Receptors, Peptide; Receptors, Somatostatin; Tyrosine | 2015 |
Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biomarkers, Tumor; Cell Line, Tumor; Doublecortin-Like Kinases; Epithelial-Mesenchymal Transition; Female; Focal Adhesion Kinase 1; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred BALB C; Middle Aged; Neoplastic Stem Cells; Neuroendocrine Tumors; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Tyrosine; Xenograft Model Antitumor Assays | 2017 |
Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.
Topics: Adenoma, Islet Cell; Animals; Blotting, Western; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Gastrointestinal Hormones; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction; Somatostatinoma; Transcriptional Activation; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 2013 |
Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.
Topics: Adenocarcinoma; Adenoma; Adenoma, Islet Cell; Animals; Antibodies, Neutralizing; beta Catenin; Cell Hypoxia; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Transgenic; Neuroendocrine Tumors; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Smad2 Protein; src-Family Kinases; Tyrosine; Vascular Endothelial Growth Factor A | 2013 |
Aromatic L-amino acid decarboxylase (AAAD) inhibitors as carcinoid tumor-imaging agents: synthesis of 18F-labeled alpha-fluoromethyl-6-fluoro-m-tyrosine (FM-6-FmT).
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Carcinoid Tumor; Fluorine Radioisotopes; Humans; Isotope Labeling; Neuroendocrine Tumors; Protein Binding; Radioligand Assay; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine | 2003 |
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine | 2001 |